• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Exendin-4 通过 AMPK/SIRT1/FOXO3a 信号通路促进血管平滑肌细胞再分化。

Exendin-4 promotes the vascular smooth muscle cell re-differentiation through AMPK/SIRT1/FOXO3a signaling pathways.

机构信息

Institute of Cardiovascular Science, Beijing, 100191, China; Key Laboratory of Molecular Cardiovascular Science of Ministry of Education, Peking University Health Science Center, Beijing, 100191, China.

Institute of Cardiovascular Science, Beijing, 100191, China; Key Laboratory of Molecular Cardiovascular Science of Ministry of Education, Peking University Health Science Center, Beijing, 100191, China.

出版信息

Atherosclerosis. 2018 Sep;276:58-66. doi: 10.1016/j.atherosclerosis.2018.07.016. Epub 2018 Jul 21.

DOI:10.1016/j.atherosclerosis.2018.07.016
PMID:30036742
Abstract

BACKGROUND AND AIMS

The phenotype switching of vascular smooth muscle cells (VSMCs) plays a key role during development and progression of vascular remodeling diseases. Recent studies show that GLP-1 can inhibit intima thickening to delay the progression of atherosclerotic plaques. The purpose of this study was to investigate the role of Exendin-4, a GLP-1 receptor agonist, in VSMCs phenotype switching and the related mechanisms.

METHODS

Immunohistochemistry and Western blot were used to detect the effect of Exendin-4 on expression of markers of contractile VSMCs. Phalloidin staining was performed to observe the effect of Exendin-4 on morphology of VSMCs.

RESULTS

Exendin-4 significantly increased the protein levels of contractile VSMCs markers like Calponin and SM22α. After treatment of Exendin-4, VSMCs showed more typical characteristic spindle shape. In addition, Exendin-4 significantly upregulated the phosphorylation of AMPK as well as the protein levels of Sirtuin1 (SIRT1) and FOXO3a in VSMCs. After inhibiting AMPK activity with compound C and SIRT1 activity with EX527, and knocking down FOXO3a expression through RNAi technique, Exendin-4 increased the protein levels of Calponin and SM22α and promoted the redifferentiation of VSMCs mainly through AMPK/SIRT1/FOXO3a signaling pathways.

CONCLUSIONS

Exendin-4 can regulate the phenotype switching of VSMCs and promote redifferentiation of VSMCs through AMPK/SIRT1/FOXO3a signaling pathways.

摘要

背景与目的

血管平滑肌细胞(VSMCs)的表型转换在血管重塑疾病的发展和进展中起着关键作用。最近的研究表明,GLP-1 可以抑制内膜增厚,从而延缓动脉粥样硬化斑块的进展。本研究旨在探讨 GLP-1 受体激动剂 Exendin-4 在 VSMCs 表型转换中的作用及其相关机制。

方法

采用免疫组织化学和 Western blot 检测 Exendin-4 对收缩型 VSMCs 标志物表达的影响。用鬼笔环肽染色观察 Exendin-4 对 VSMCs 形态的影响。

结果

Exendin-4 显著增加了收缩型 VSMCs 标志物如 Calponin 和 SM22α 的蛋白水平。经 Exendin-4 处理后,VSMCs 呈现出更典型的特征性梭形。此外,Exendin-4 显著上调了 VSMCs 中 AMPK 的磷酸化以及 Sirtuin1(SIRT1)和 FOXO3a 的蛋白水平。用化合物 C 抑制 AMPK 活性、用 EX527 抑制 SIRT1 活性、用 RNAi 技术敲低 FOXO3a 表达后,Exendin-4 增加了 Calponin 和 SM22α 的蛋白水平,并通过 AMPK/SIRT1/FOXO3a 信号通路主要促进 VSMCs 的再分化。

结论

Exendin-4 可以通过 AMPK/SIRT1/FOXO3a 信号通路调节 VSMCs 的表型转换,促进 VSMCs 的再分化。

相似文献

1
Exendin-4 promotes the vascular smooth muscle cell re-differentiation through AMPK/SIRT1/FOXO3a signaling pathways.Exendin-4 通过 AMPK/SIRT1/FOXO3a 信号通路促进血管平滑肌细胞再分化。
Atherosclerosis. 2018 Sep;276:58-66. doi: 10.1016/j.atherosclerosis.2018.07.016. Epub 2018 Jul 21.
2
CKII-SIRT1-SM22α loop evokes a self-limited inflammatory response in vascular smooth muscle cells.CKII-SIRT1-SM22α 环在血管平滑肌细胞中引发自我限制的炎症反应。
Cardiovasc Res. 2017 Aug 1;113(10):1198-1207. doi: 10.1093/cvr/cvx048.
3
SIRT1 and FOXO Mediate Contractile Differentiation of Vascular Smooth Muscle Cells under Cyclic Stretch.SIRT1和FOXO介导循环拉伸下血管平滑肌细胞的收缩性分化。
Cell Physiol Biochem. 2015;37(5):1817-29. doi: 10.1159/000438544. Epub 2015 Nov 13.
4
MicroRNA-132 targeting PTEN contributes to cilostazol-promoted vascular smooth muscle cell differentiation.微小 RNA-132 靶向 PTEN 促进西洛他唑促进血管平滑肌细胞分化。
Atherosclerosis. 2018 Jul;274:1-7. doi: 10.1016/j.atherosclerosis.2018.04.030. Epub 2018 Apr 26.
5
Fibroblast Growth Factor 12 Is a Novel Regulator of Vascular Smooth Muscle Cell Plasticity and Fate.成纤维细胞生长因子12是血管平滑肌细胞可塑性和命运的新型调节因子。
Arterioscler Thromb Vasc Biol. 2016 Sep;36(9):1928-36. doi: 10.1161/ATVBAHA.116.308017. Epub 2016 Jul 28.
6
Glucagon-like peptide-1 receptor agonist exendin 4 ameliorates diabetes-associated vascular calcification by regulating mitophagy through the AMPK signaling pathway.胰高血糖素样肽-1 受体激动剂 exendin-4 通过调节 AMPK 信号通路的线粒体自噬改善糖尿病相关血管钙化。
Mol Med. 2024 May 8;30(1):58. doi: 10.1186/s10020-024-00817-8.
7
Nkx2-3 induces autophagy inhibiting proliferation and migration of vascular smooth muscle cells via AMPK/mTOR signaling pathway.Nkx2-3 通过 AMPK/mTOR 信号通路诱导自噬,抑制血管平滑肌细胞的增殖和迁移。
J Cell Physiol. 2021 Nov;236(11):7342-7355. doi: 10.1002/jcp.30400. Epub 2021 Apr 30.
8
Tryptanthrin Regulates Vascular Smooth Muscle Cell Phenotypic Switching in Atherosclerosis by AMP-Activated Protein Kinase/Acetyl-CoA Carboxylase Signaling Pathway.色氨酸吡咯啉酮通过 AMP 激活的蛋白激酶/乙酰辅酶 A 羧化酶信号通路调节动脉粥样硬化中的血管平滑肌细胞表型转换。
J Cardiovasc Pharmacol. 2021 May 1;77(5):642-649. doi: 10.1097/FJC.0000000000001008.
9
Liraglutide, a GLP-1 receptor agonist, inhibits vascular smooth muscle cell proliferation by enhancing AMP-activated protein kinase and cell cycle regulation, and delays atherosclerosis in ApoE deficient mice.利拉鲁肽是一种胰高血糖素样肽-1(GLP-1)受体激动剂,它通过增强AMP激活的蛋白激酶和细胞周期调节来抑制血管平滑肌细胞增殖,并延缓载脂蛋白E缺乏小鼠的动脉粥样硬化进程。
Atherosclerosis. 2017 Jun;261:44-51. doi: 10.1016/j.atherosclerosis.2017.04.001. Epub 2017 Apr 7.
10
Targeting AGGF1 (angiogenic factor with G patch and FHA domains 1) for Blocking Neointimal Formation After Vascular Injury.靶向AGGF1(含G结构域和FHA结构域的血管生成因子1)以阻断血管损伤后的新生内膜形成。
J Am Heart Assoc. 2017 Jun 25;6(6):e005889. doi: 10.1161/JAHA.117.005889.

引用本文的文献

1
Targeting Sarcopenia in CKD: The Emerging Role of GLP-1 Receptor Agonists.靶向慢性肾脏病中的肌肉减少症:胰高血糖素样肽-1受体激动剂的新作用
Int J Mol Sci. 2025 Aug 21;26(16):8096. doi: 10.3390/ijms26168096.
2
Targeting Diabetic Atherosclerosis: The Role of GLP-1 Receptor Agonists, SGLT2 Inhibitors, and Nonsteroidal Mineralocorticoid Receptor Antagonists in Vascular Protection and Disease Modulation.靶向糖尿病动脉粥样硬化:胰高血糖素样肽-1受体激动剂、钠-葡萄糖协同转运蛋白2抑制剂和非甾体盐皮质激素受体拮抗剂在血管保护和疾病调节中的作用
Biomedicines. 2025 Mar 17;13(3):728. doi: 10.3390/biomedicines13030728.
3
Finerenone attenuates downregulation of the kidney GLP-1 receptor and glucagon receptor and cardiac GIP receptor in mice with comorbid diabetes.
非奈利酮可减轻合并糖尿病小鼠肾脏中胰高血糖素样肽-1受体和胰高血糖素受体以及心脏中葡萄糖依赖性促胰岛素多肽受体的下调。
Diabetol Metab Syndr. 2024 Nov 24;16(1):283. doi: 10.1186/s13098-024-01525-3.
4
Anti-atherosclerotic effect of incretin receptor agonists.肠促胰岛素受体激动剂的抗动脉粥样硬化作用。
Front Endocrinol (Lausanne). 2024 Oct 18;15:1463547. doi: 10.3389/fendo.2024.1463547. eCollection 2024.
5
Mechanisms of ferroptosis and glucagon-like peptide-1 receptor agonist in post-percutaneous coronary intervention restenosis.铁死亡机制与胰高血糖素样肽-1受体激动剂在经皮冠状动脉介入治疗后再狭窄中的作用
Mol Cell Biochem. 2025 Mar;480(3):1465-1480. doi: 10.1007/s11010-024-05118-6. Epub 2024 Sep 16.
6
Semaglutide Alleviates Ovary Inflammation via the AMPK/SIRT1/NF‑κB Signaling Pathway in Polycystic Ovary Syndrome Mice.司美格鲁肽通过 AMPK/SIRT1/NF-κB 信号通路缓解多囊卵巢综合征小鼠的卵巢炎症。
Drug Des Devel Ther. 2024 Sep 4;18:3925-3938. doi: 10.2147/DDDT.S484531. eCollection 2024.
7
Cardiovascular Protective Properties of GLP-1 Receptor Agonists: More than Just Diabetic and Weight Loss Drugs.胰高血糖素样肽-1受体激动剂的心血管保护特性:不仅仅是糖尿病和减肥药物。
J Clin Med. 2024 Aug 9;13(16):4674. doi: 10.3390/jcm13164674.
8
Multi-Omics Approaches for Liver Reveal the Thromboprophylaxis Mechanism of Aspirin Eugenol Ester in Rat Thrombosis Model.多组学方法研究肝脏揭示了阿司匹林丁香酚酯在大鼠血栓模型中的抗栓作用机制。
Int J Mol Sci. 2024 Feb 10;25(4):2141. doi: 10.3390/ijms25042141.
9
Quercetin and AMPK: A Dynamic Duo in Alleviating MG-Induced Inflammation via the AMPK/SIRT1/NF-κB Pathway.槲皮素和 AMPK:通过 AMPK/SIRT1/NF-κB 通路缓解 MG 诱导的炎症的动态双元体。
Molecules. 2023 Nov 2;28(21):7388. doi: 10.3390/molecules28217388.
10
Incretins-Based Therapies and Their Cardiovascular Effects: New Game-Changers for the Management of Patients with Diabetes and Cardiovascular Disease.基于肠促胰岛素的疗法及其心血管效应:糖尿病和心血管疾病患者管理的新变革者。
Pharmaceutics. 2023 Jul 1;15(7):1858. doi: 10.3390/pharmaceutics15071858.